Decoding BeiGene Ltd (BGNE): A Strategic SWOT Insight [Yahoo! Finance]
BeiGene, Ltd. - American Depositary Shares (BGNE)
Last beigene, ltd. - american depositary shares earnings: 3/2 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.beigene.com/phoenix.zhtml?c=254246&p=irol-irhome_pf
Company Research
Source: Yahoo! Finance
Research and development expenses reflect the company's commitment to innovation and pipeline expansion. Despite increased revenues, BeiGene Ltd ( NASDAQ:BGNE ) faces operational losses and challenges in net income. The company's strategic focus on oncology therapeutics and global clinical trials positions it for potential market leadership. Warning! GuruFocus has detected 4 Warning Signs with BGNE. BeiGene Ltd ( NASDAQ:BGNE ), a biotechnology firm specializing in oncology therapeutics, has released its 10-Q filing on November 12, 2024. The financial overview reveals a company experiencing substantial growth in product revenue, which climbed from $595,290 in the third quarter of 2023 to $993,447 in the same period of 2024. Collaboration revenue, however, has seen a decline, dropping from $186,018 to $8,152 year-over-year. Despite the increase in total revenues, which rose from $781,308 to $1.00 million, BeiGene Ltd ( NASDAQ:BGNE ) reported a net loss of $121,350 for the quart
Show less
Read more
Impact Snapshot
Event Time:
BGNE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BGNE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BGNE alerts
High impacting BeiGene, Ltd. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
BGNE
News
- BeiGene, Ltd. (NASDAQ: BGNE) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- BeiGene Announces Settlement of Litigation Against Generic Filer of BRUKINSABusiness Wire
- BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against CancerBusiness Wire
- BeiGene, Ltd. (NASDAQ: BGNE) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- BeiGene, Ltd. (NASDAQ: BGNE) had its price target raised by analysts at TD Cowen from $254.00 to $260.00. They now have a "buy" rating on the stock.MarketBeat
BGNE
Earnings
- 11/12/24 - Miss
BGNE
Sec Filings
- 11/19/24 - Form 8-K
- 11/14/24 - Form 8-K
- 11/12/24 - Form 10-Q
- BGNE's page on the SEC website